17th Annual International Ultmann Chicago Lymphoma Symposium

August 28, 2020 to August 29, 2020
The International Ultmann Chicago Lymphoma Symposium (IUCLS) is an annual conference dedicated solely to the science and clinical care of lymphoma. It has been organized to honor the achievements of Dr. John Ultmann, a pioneer in the treatment of lymphoma, who devoted his life to the understanding of this disease. He was particularly known for his work on the staging of Hodgkin lymphoma and the utility of staging as a guide for treatment.

We are fortunate to have a multitude of the world’s experts in lymphoma speak each year at the conference. The audience is comprised of regional practicing oncologists, advanced nurse practitioners and physician assistants, residents, fellows, and the Chicago academic community that includes five academic centers. Next year’s program offered in 2020 represents the 17th IUCLS.

This is a certified continuing medical education (CME) activity that focuses on the biologic, diagnostic, and therapeutic aspects of Hodgkin lymphoma and non-Hodgkin lymphoma. The format of the meeting includes a combination of expert presentations, interactive case discussions, poster/abstract presentations, and an opportunity for question-and-answer debates. The IUCLS is a two-day meeting held Friday afternoon and Saturday morning and early afternoon. Friday afternoon concentrates on the scientific and translational aspects of lymphoma, while Saturday has a clinical focus.

Learn more at the symposium website!

Target Audience

This activity is designed for practicing oncologists, advanced nurse practitioners, physician assistants, residents, fellows, nurses, pharmacists and the other healthcare professionals interested in the treatment and diagnosis of lymphoma.

Learning Objectives

At the conclusion of this educational activity, participants will be able to:

  • Distinguish between the different treatment approaches for newly diagnosed T-cell lymphoma and mantle cell lymphoma
  • Discuss the role of allogeneic stem cell transplant in Hodgkin lymphoma treatment
  • Identify patient characteristics best suited for CAR T-cell treatment
  • Differentiate between the different lymphoma staging and re-staging classifications to develop an appropriate patient treatment plan
  • Evaluate the different treatment options for follicular lymphoma and the risk of transformation to other cancers
  • State key environmental and genetics risks for lymphoma and the roles they play in lymphoid malignancies
  • Outline key molecular and cytogenetic information in order to determine best treatment options for chronic lymphocytic leukemia
  • Determine short and long-term toxicities of cardiotoxic agents used in lymphoma treatment
  • Describe how epigenetic targets in lymphoid cancers can be used to improve patient outcomes
  • List non-chemotherapy options for follicular lymphoma
Additional information
ABMS Core Competencies: 
Patient Care and Procedural Skills
Medical Knowledge
Practice-based Learning and Improvement
Interpersonal and Communication Skills
For more information, please contact:
CME Coordinator Contact Name: 
Conference Secretariat
CME Coordinator Contact Email: 
Available credit: 
  • 11.75 AMA PRA Category 1 Credit™
  • 11.75 Nursing Contact Hours
  • 11.75 Participation
Event starts: 
08/28/2020 - 8:00am
Event ends: 
08/29/2020 - 1:30pm
Activity opens: 
Activity expires: 

Virtual Symposium
Chicago, IL
United States
In light of recommended procedures from leading health officials and organizations in the prevention of COVID-19, course leadership have considered the safety of learners and faculty alike. In order to ensure everyone's safety but still provide these important updates, course leadership have opted to continue the activity virtually!

ACCESSIBILITY The University of Chicago is committed to providing equal access appropriate to need and circumstances and complies fully with legal requirements of the Americans with Disabilities Act. If you are in need of special accommodation, please contact our office via e-mail at iucls@bioascend.com.

The University of Chicago reserves the right to cancel or postpone this conference due to unforeseen circumstances. In the unlikely event this activity must be cancelled or postponed, the registration fee will be refunded; however, The University of Chicago is not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.

  Sonali M. Smith, MD
  Elwood V. Jensen Professor of Medicine
  Section of Hematology/Oncology
  Director, Lymphoma Program
  The University of Chicago
  Andrew M. Evens, DO, MSc
  Associate Director for Clinical Services, Rutger Cancer Institute of New Jersey
  Medical Director, Oncology Service Line, RWJBarnabas Health
  Director, Lymphoma Program, Division of Blood Disorders
  Professor of Medicine, Rutgers Robert Wood Johnson Medical School
  Barbara Pro, MD
  Professor of Medicine
  Division of Hematology/Oncology
  Northwestern University
  Feinberg School of Medicine

Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.

Additionally, The University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.

Physician Credit
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 11.75 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Credit
The University of Chicago Medicine is an approved provider of continuing nursing education by the Ohio Nurses Association, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. (OBN-001-91)

This live activity is designated for a maximum of 11.75 continuing nursing education units.
American Board of Internal Medicine MOC Part II Credit
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 11.75 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Other Healthcare Professions Credit
Other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of certificates of participation for educational activities certified for AMA PRA Category 1 CreditsTM from organizations accredited by the ACCME, please consult your professional licensing board.

Please Note: Requests to claim MOC Part II credit must be made within one month to report to ABIM. Requests to claim AMA PRA Category 1 Credit™ after three months will be subject to additional fees.

REGISTRATION: Select the registration type based that best suits you. Then click "Register Now!" and simply follow the prompts to complete your registration.
To help meet your educational needs, we offer three options of sessions you can attend:
  1. BOTH the Symposium and the Nursing Session
  2. ONLY the Symposium
  3. ONLY the Nursing Session
Choose the option that’s best for you!

JOINING THE SYMPOSIUM: Enter the virtual symposium platform by clicking the button below!

Log in with the e-mail used to register and the password provided by commpartners.com at that same e-mail.

Onsite/Day of Registrants: Please wait 15-20 minutes post-registration to allow the tech team to generate your access. You will receive an e-mail once that process has completed, confirming your access.

For technical issues, contact: CLSupport@meetingachievements.com


CLAIMING CREDIT: At the end of the course, the credit claiming process will unlock. Return to this page and simply click on "Complete Activity" to proceed.
Please Note: Requests to claim MOC Part II credit must be made within one month to report to ABIM. Requests to claim AMA PRA Category 1 Credit™ after three months will be subject to additional fees.


1. Symposium AND Nursing Session
Profession Type
Regular Registration
2. Symposium ONLY
Profession TypeRegular Registration
3. Nursing Session ONLY
Profession TypeRegular Registration

CANCELLATION POLICY  A refund of 50% will be offered after June 2, 2020 and no refunds will be issued after August 1, 2020.
Please login or create an account to proceed.